Dual‐Responsive Nanorobot‐Based Marsupial Robotic System for Intracranial Cross‐Scale Targeting Drug Delivery
Advanced Materials · 2024
DOI: 10.1002/adma.202306876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Junfeng Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, 110016, China. Hauptthemen laut MEDLINE: Glioblastoma, Robotic Surgical Procedures, Marsupialia. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: CAS Project for Young Scientists in Basic Research, National Natural Science Foundation of China, CAS/SAFEA International Partnership Program for Creative Research Teams.
Abstract (Originalsprache)
Nanorobots capable of active movement are an exciting technology for targeted therapeutic intervention. However, the extensive motion range and hindrance of the blood–brain barrier impeded their clinical translation in glioblastoma therapy. Here, a marsupial robotic system constructed by integrating chemical/magnetic hybrid nanorobots (child robots) with a miniature magnetic continuum robot (mother robot) for intracranial cross‐scale targeting drug delivery is reported. For primary targeting on macroscale, the continuum robot enters the cranial cavity through a minimally invasive channel (e.g., Ommaya device) in the skull and transports the nanorobots to pathogenic regions. Upon circumventing the blood–brain barrier, the released nanorobots perform secondary targeting on microscale to further enhance the spatial resolution of drug delivery. In vitro experiments against primary glioblastoma cells derived from different patients are conducted for personalized treatment guidance. The operation feasibility within organisms is shown in ex vivo swine brain experiments. The biosafety of the treatment system is suggested in in vivo experiments. Owing to the hierarchical targeting method, the targeting rate, targeting accuracy, and treatment efficacy have improved greatly. The marsupial robotic system offers a novel intracranial local therapeutic strategy and constitutes a key milestone in the development of glioblastoma treatment platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, 110016, China.
- Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, 110016, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, 110022, China.
- Department of Mechanical Engineering, University of Arkansas, Arkansas, 72701, USA.
ORCID-Profile: Niandong Jiao
Förderung
- CAS Project for Young Scientists in Basic Research
- National Natural Science Foundation of China
- CAS/SAFEA International Partnership Program for Creative Research Teams
Zitieren
APA
Wu, J., Jiao, N., Lin, D., Li, N., Ma, T., Tung, S., Cheng, W., Wu, A., & Liu, L. (2024). Dual‐Responsive Nanorobot‐Based Marsupial Robotic System for Intracranial Cross‐Scale Targeting Drug Delivery. Advanced Materials. https://doi.org/10.1002/adma.202306876
Vancouver
Wu J, Jiao N, Lin D, Li N, Ma T, Tung S, et al. Dual‐Responsive Nanorobot‐Based Marsupial Robotic System for Intracranial Cross‐Scale Targeting Drug Delivery. Advanced Materials. 2024. doi:10.1002/adma.202306876
BibTeX
@article{Wu2024,
author = {Wu, Junfeng and Jiao, Niandong and Lin, Daojing and Li, Na and Ma, Tianyang and Tung, Steve and Cheng, Wen and Wu, Anhua and Liu, Lianqing},
title = {Dual‐Responsive Nanorobot‐Based Marsupial Robotic System for Intracranial Cross‐Scale Targeting Drug Delivery},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202306876}
}
EUVIMED